287 related articles for article (PubMed ID: 26893072)
1. CMKLR1 deficiency maintains ovarian steroid production in mice treated chronically with dihydrotestosterone.
Tang M; Huang C; Wang YF; Ren PG; Chen L; Xiao TX; Wang BB; Pan YF; Tsang BK; Zabel BA; Ma BH; Zhao HY; Zhang JV
Sci Rep; 2016 Feb; 6():21328. PubMed ID: 26893072
[TBL] [Abstract][Full Text] [Related]
2. Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes/macrophages.
Lima PDA; Nivet AL; Wang Q; Chen YA; Leader A; Cheung A; Tzeng CR; Tsang BK
Biol Reprod; 2018 Oct; 99(4):838-852. PubMed ID: 29688269
[TBL] [Abstract][Full Text] [Related]
3. Chemerin, a novel regulator of follicular steroidogenesis and its potential involvement in polycystic ovarian syndrome.
Wang Q; Kim JY; Xue K; Liu JY; Leader A; Tsang BK
Endocrinology; 2012 Nov; 153(11):5600-11. PubMed ID: 22948218
[TBL] [Abstract][Full Text] [Related]
4. The polycystic ovary syndrome-associated gene Yap1 is regulated by gonadotropins and sex steroid hormones in hyperandrogenism-induced oligo-ovulation in mouse.
Ji SY; Liu XM; Li BT; Zhang YL; Liu HB; Zhang YC; Chen ZJ; Liu J; Fan HY
Mol Hum Reprod; 2017 Oct; 23(10):698-707. PubMed ID: 28961951
[TBL] [Abstract][Full Text] [Related]
5. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
6. Chemerin suppresses ovarian follicular development and its potential involvement in follicular arrest in rats treated chronically with dihydrotestosterone.
Kim JY; Xue K; Cao M; Wang Q; Liu JY; Leader A; Han JY; Tsang BK
Endocrinology; 2013 Aug; 154(8):2912-23. PubMed ID: 23696570
[TBL] [Abstract][Full Text] [Related]
7. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic kiss1 mRNA and kisspeptin immunoreactivity are reduced in a rat model of polycystic ovary syndrome (PCOS).
Brown RE; Wilkinson DA; Imran SA; Caraty A; Wilkinson M
Brain Res; 2012 Jul; 1467():1-9. PubMed ID: 22668987
[TBL] [Abstract][Full Text] [Related]
9. Reproductive and metabolic phenotype of a mouse model of PCOS.
van Houten EL; Kramer P; McLuskey A; Karels B; Themmen AP; Visser JA
Endocrinology; 2012 Jun; 153(6):2861-9. PubMed ID: 22334715
[TBL] [Abstract][Full Text] [Related]
10. Involvement of chemerin and CMKLR1 in the progesterone decrease by PCOS granulosa cells.
Estienne A; Mellouk N; Bongrani A; Plotton I; Langer I; Ramé C; Petit C; Guérif F; Froment P; Dupont J
Reproduction; 2021 Oct; 162(6):427-436. PubMed ID: 34605770
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptors in the uterus and ovarian follicles of gilts treated with dihydrotestosterone.
Cárdenas H; Pope WF
Domest Anim Endocrinol; 2005 Oct; 29(3):523-33. PubMed ID: 16153501
[TBL] [Abstract][Full Text] [Related]
12. Regulation of androgen receptor signaling by ubiquitination during folliculogenesis and its possible dysregulation in polycystic ovarian syndrome.
Lim JJ; Lima PDA; Salehi R; Lee DR; Tsang BK
Sci Rep; 2017 Aug; 7(1):10272. PubMed ID: 28860512
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin protects against development of metabolic disturbances in a PCOS mouse model.
Benrick A; Chanclón B; Micallef P; Wu Y; Hadi L; Shelton JM; Stener-Victorin E; Wernstedt Asterholm I
Proc Natl Acad Sci U S A; 2017 Aug; 114(34):E7187-E7196. PubMed ID: 28790184
[TBL] [Abstract][Full Text] [Related]
14. CMKLR1 deficiency attenuates androgen-induced lipid accumulation in mice.
Huang B; Zhao H; Huang C; Wu L; Xiang L; Chen J; Wang B; Xiao T; Li M; Ren L; Niu J; Zhang JV
Am J Physiol Endocrinol Metab; 2020 Mar; 318(3):E371-E380. PubMed ID: 31910029
[TBL] [Abstract][Full Text] [Related]
15. Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization.
Caldwell AS; Eid S; Kay CR; Jimenez M; McMahon AC; Desai R; Allan CM; Smith JT; Handelsman DJ; Walters KA
Endocrinology; 2015 Apr; 156(4):1441-52. PubMed ID: 25643156
[TBL] [Abstract][Full Text] [Related]
16. Kisspeptin in the Hypothalamus of 2 Rat Models of Polycystic Ovary Syndrome.
Osuka S; Iwase A; Nakahara T; Kondo M; Saito A; Bayasula ; Nakamura T; Takikawa S; Goto M; Kotani T; Kikkawa F
Endocrinology; 2017 Feb; 158(2):367-377. PubMed ID: 27983870
[TBL] [Abstract][Full Text] [Related]
17. The Role of Bone Morphogenetic Protein 4 in Ovarian Function and Diseases.
Yang D; Yang X; Dai F; Wang Y; Yang Y; Hu M; Cheng Y
Reprod Sci; 2021 Dec; 28(12):3316-3330. PubMed ID: 33966186
[TBL] [Abstract][Full Text] [Related]
18. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
Mannerås L; Cajander S; Holmäng A; Seleskovic Z; Lystig T; Lönn M; Stener-Victorin E
Endocrinology; 2007 Aug; 148(8):3781-91. PubMed ID: 17495003
[TBL] [Abstract][Full Text] [Related]
19. Endocrine traits of polycystic ovary syndrome in prenatally androgenized female Sprague-Dawley rats.
Wu XY; Li ZL; Wu CY; Liu YM; Lin H; Wang SH; Xiao WF
Endocr J; 2010; 57(3):201-9. PubMed ID: 20057162
[TBL] [Abstract][Full Text] [Related]
20. The follicle-deplete mouse ovary produces androgen.
Mayer LP; Devine PJ; Dyer CA; Hoyer PB
Biol Reprod; 2004 Jul; 71(1):130-8. PubMed ID: 14998904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
